Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Other Disease Areas
Filter     Order     Display # 
Date Item Title
02 Oct 2008 OPKO Acquires Worldwide Ophthalmic Rights to Teva's Budesonide for Inflammatory and Allergic Ocular Conditions
02 Oct 2008 Æterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
01 Oct 2008 Ore Pharmaceuticals Begins Clinical Trial of GL1001
29 Sep 2008 Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
29 Sep 2008 Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
29 Sep 2008 Columbia Laboratories Reports Results from Phase II Clinical Trial of Vaginally-administered Lidocaine for Dysmenorrhea
29 Sep 2008 Watson Announces Positive Data for RAPAFLO(TM)(silodosin), Its Investigational Product for BPH, at Regional AUA Conferences
29 Sep 2008 VEGF Trap-Eye Final Phase 2 Results in Age-related Macular Degeneration Presented at 2008 Retina Society Meeting
25 Sep 2008 Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
25 Sep 2008 Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial
25 Sep 2008 Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
24 Sep 2008 Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
23 Sep 2008 iCo Therapeutics Provides Interim Trial Results (Diffuse Diabetic Macular Edema)
23 Sep 2008 Galmed Medical Research Initiates Phase I Study of Aramchol, Leading Drug Candidate for Fatty Liver Disease
22 Sep 2008 RegeneRx/Sigma-Tau Complete Patient Enrollment of Second Phase II Clinical Trial with RGN-137
22 Sep 2008 Paion Announces Phase I Study With Sedative/Anaesthetic CNS 7056 Progressed to Midazolam Comparison
21 Sep 2008 Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) for Chronic Idiopathic Constipation
17 Sep 2008 Depomed Initiates Phase 3 Program in Menopausal Hot Flashes
17 Sep 2008 Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(TM) Phase IIb Study for Peyronie's Disease
17 Sep 2008 Biovitrum begins Exinalda(TM) study with cystic fibrosis patients with fat malabsorption
15 Sep 2008 Othera Initiates Phase I/II Clinical Trial of OT-730 In Ocular Hypertension and Glaucoma
14 Sep 2008 Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
09 Sep 2008 BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company's Dermatology Product
08 Sep 2008 BioSante Pharmaceuticals Announces Positive Oral Contraceptive Clinical Results
08 Sep 2008 ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
08 Sep 2008 Asterand to Enter Into Exclusive License Agreement with Allergan for Pre-Clinical Compounds Focused on Diseases of the Eye
08 Sep 2008 Basilea’s Toctino® (alitretinoin) receives first national marketing authorization in the UK
04 Sep 2008 Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
04 Sep 2008 Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
04 Sep 2008 Nanotherapeutics Files Investigational New Drug Application for NanoDOX(TM) Hydrogel to Treat Lower Extremity Diabetic Ulcers
03 Sep 2008 Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
03 Sep 2008 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
03 Sep 2008 Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
03 Sep 2008 Plexxikon Initiates Phase 1 Trial for PLX5568
03 Sep 2008 Discovery Labs' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
03 Sep 2008 Discovery Labs' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
03 Sep 2008 Protox completes enrollment of Phase 2 BPH trial
02 Sep 2008 Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
31 Aug 2008 Takeda and Affymax Provide Clinical Development Update for Hematide(TM) in Chemotherapy-induced Anemia
28 Aug 2008 Alseres Pharmaceuticals Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing
27 Aug 2008 NICE final guidance recommends Lucentis(R) as cost-effective treatment for wet AMD, a leading cause of blindness
26 Aug 2008 Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
25 Aug 2008 Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
25 Aug 2008 NicOx provides update on PF-03187207 and the ongoing research collaboration with Pfizer
21 Aug 2008 Kamada Successfully Completes Phase II Trial with Aerosolized AAT in Cystic Fibrosis Patients
21 Aug 2008 Auris Medical reporting results of phase I/II clinical trial with AM-101
21 Aug 2008 PTC124 shows promising activity in Cystic Fibrosis; phase 2 proof-of-concept data published in the lancet
20 Aug 2008 PregLem starts Phase III trials of PGL4001 in Uterine Myoma
20 Aug 2008 RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial
19 Aug 2008 Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 51 - 100 of 985

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics